Pflug Koory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $911K | Buy |
2,046
+52
| +3% | +$23.2K | 0.46% | 60 |
|
|
2025
Q1 | $967K | Sell |
1,994
-24
| -1% | -$11.6K | 0.54% | 58 |
|
|
2024
Q4 | $813K | Buy |
2,018
+79
| +4% | +$31.8K | 0.41% | 62 |
|
|
2024
Q3 | $902K | Buy |
+1,939
| New | +$902K | 0.44% | 63 |
|
|
2024
Q1 | $758K | Buy |
1,813
+2
| +0.1% | +$836 | 0.37% | 70 |
|
|
2023
Q4 | $737K | Hold |
1,811
| – | – | 0.39% | 69 |
|
|
2023
Q3 | $630K | Sell |
1,811
-10
| -0.5% | -$3.48K | 0.36% | 73 |
|
|
2023
Q2 | $641K | Sell |
1,821
-30
| -2% | -$10.6K | 0.33% | 80 |
|
|
2023
Q1 | $583K | Hold |
1,851
| – | – | 0.32% | 82 |
|
|
2022
Q4 | $535K | Sell |
1,851
-15
| -0.8% | -$4.34K | 0.3% | 90 |
|
|
2022
Q3 | $540K | Hold |
1,866
| – | – | 0.33% | 80 |
|
|
2022
Q2 | $526K | Hold |
1,866
| – | – | 0.3% | 86 |
|
|
2022
Q1 | $487K | Sell |
1,866
-10
| -0.5% | -$2.61K | 0.25% | 93 |
|
|
2021
Q4 | $412K | Buy |
1,876
+885
| +89% | +$194K | 0.21% | 105 |
|
|
2021
Q3 | $180K | Sell |
991
-175
| -15% | -$31.8K | 0.1% | 166 |
|
|
2021
Q2 | $235K | Buy |
1,166
+682
| +141% | +$137K | 0.12% | 152 |
|
|
2021
Q1 | $104K | Buy |
+484
| New | +$104K | 0.06% | 194 |
|